Board of Directors

Our Board of Directors is comprised of healthcare investors, academics, pharma industry veterans, and biotech entrepreneurs. They are guiding our long-term strategic plan and assisting us in advancing our mission to develop novel therapies to cure cancers.

William Coffin

Chair of the Corporate Governance Committee

Milton 2_edited_edited.jpg

Milton Brown, MD,PhD

Board Member

Dr. Brown is a co-founder of the Company and has served as our Chief Scientific Officer for Chemistry and as a member of our board of directors since we were formed in December 2012. Dr. Brown was a founder in 2004 of Rivanna Pharmaceuticals, a Virginia-based biopharmaceutical company engaged in the discovery and development of novel small molecule therapeutics for the treatment of neurological diseases and cancer. Since 2012, Dr. Brown has served as Director of the Drug Discovery Center at Georgetown University Medical School and since 2010, he has been the principal investigator of the NIH/NCI funded Chemical Diversity Center. He brings to Shuttle 15 years of experience in drug discovery with over 80 publications and eight issued patents, including discovery of novel HDAC inhibitors and has two drugs currently in clinical trials. He has served on government committees including the NIH Experimental Therapeutics Study Section, the NIH Drug Discovery and Molecular Pharmacology Study Section and was a scientific counselor to the U.S. Secretary of Health. Dr. Brown holds a Ph.D. in synthetic chemistry from University of Alabama, and an MD from the University of Virginia. He is uniquely qualified to direct Shuttle’s drug discovery program and serve as our director.

Steve Pic.jpg

Steve Richards, MBA

Chair of Audit Committee

Mr. Richards was appointed to Director on the Company’s Board of Directors in 2019. He is CEO and Founder of Endurance Media, a media finance company based in Santa Monica, California, that launched in 2014 with a strategic alliance with eOne Entertainment with a mandate to produce and finance commercially driven feature films. From 2006 to 2014, Mr. Richards served as Co-President and Chief Operating Officer of Silver Pictures where he oversaw all business activities and managed a team of more than 20 people responsible for film development, production and financial information. From 2000 to 2006, he served as Chief Financial Officer at Silver Pictures and from 1995 to 2000 as Vice President, Finance, at Silver Pictures. Mr. Richards holds an MBA in Finance from UCLA, a BBA in accounting from Temple University, and holds his CPA license. We believe his experience as a chief financial officer and in accounting will assist in providing our board guidance and oversight as we grow our Company.

William Coffin

Chair of the Corporate Governance Committee

Mr. Coffin was appointed to Director on the Company’s Board of Directors in 2019. He is Chairman Emeritus of the Board of the California Counsel on Economic Education, one of California’s largest providers of economics and financial literacy training for K-12 teachers and students.  From its founding in 1972 until his retirement in 2013, Mr. Coffin was founder and Chief Executive Officer of CCG Investor Relations (“CCIG”), which during the years of his leadership was one of the nation’s largest consulting services to public and private companies, with offices in Los Angeles, New York and Hong Kong.  Through CCIG, Mr. Coffin worked with hundreds of companies as they took their businesses public and uplisting to Nasdaq and the New York Stock Exchange.  He has worked with companies engaged in other capital formation projects including mergers and acquisitions, follow-on offerings and proxy contests. Mr. Coffin received his BS in business administration from California State University, Los Angeles and has continued his studies at Anderson Business School at University of California Los Angeles.

J Schafer.jpeg

Joshua M. Schafer, MBA

Chair of Compensation Committee

Mr. Schafer was appointed to Director on the Company’s Board of Directors in 2019.  Since 2015, he has served as Vice President and Head of Business Development and Strategy for Autoimmune and Rare Diseases at Mallinckrodt Pharmaceuticals Incorporated.  From 2009 until 2015, he served as Vice President and Oncology Therapeutic Area Head, Global Marketing and Strategy at Astellas Pharmaceuticals Incorporated, where he was responsible for building the company’s global oncology franchise.  From 2000 until 2009, Mr. Schafer served in positions of increasing seniority at Takeda Pharmaceuticals North America, including Manager and Senior Manager, New Product and New Business Development; Senior Product Manager, Gastrointestinal Marketing; and Director, Oncology and Renal Marketing and Commercial Development. He began working in the healthcare and pharmaceutical industry in 1998, and has served in various positions at Accenture (formerly Anderson Consulting), G. D. Searle & Co. (later acquired by Pfizer) and Cognia Corporation.  He received his BA in Biology and German at the University of Notre Dame, his MS in Biotechnology from Northwestern University and his MBA from Northwestern University.  We believe Mr. Schafer’s extensive experience in pharmaceutical marketing and business development will assist our board’s oversight role as we build and develop our Company.


Tae Heum (Ted) Jeong

Board Member

Dr. Jeong was appointed to the position of Director on the Company’s Board of Directors in 2019. Since 2018, he has served as Managing Partner at KSV Global Innovations, a venture capital fund. From 2002 through 2018, Dr. Jeong served in various roles of progressive responsibility at Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN), including Chief Financial Officer and Director, where he played key roles in the company’s business development, private placement, underwritten and registered direct public offerings. From 1997 until 2002, Dr. Jeong served as Senior Investment Manager at Hyundai Venture Investment Corporation, a subsidiary of Hyundai Motors conglomerate and one of the largest venture capital firms in South Korea, where he specialized in venture capital investments in the healthcare industry and assisted in taking numerous companies public. Dr. Jeong holds a BS and MS in Chemistry from Pohang University of Science and Technology in Pohang, South Korea, an MS in Finance from Johns Hopkins University, and a Doctor of Management from the University of Maryland, University College. We believe Dr. Jeong’s substantial public company finance experience will assist the Company in its public reporting and funding activities as we grow and develop our Company.

Bil Adkins Picture.png

William H. Adkins

Board Member

Mr. Adkins was appointed to the position of Director on the Company's Board of Directors in 2019. From 2018 to present, Mr. Adkins has worked as a consultant to businesses, working with business owners to develop strategy, planning and problem solving, especially as concerns developing strategic goals, performance plans and marketing strategies. From 2014 until present, Mr. Adkins has served as a Strategic Business Development Manager at automotiveMastermind Inc., where he was responsible for training dealer candidates and general management, including consulting with dealers and interviewing applicants for management instructor positions. From 1985 until 2003, Mr. Adkins was President and General Manager at Chevrolet dealerships in Ohio, California and New York, including Adkins Chevrolet Buick Oldsmobile, Bayview Lincoln Mercury and Palanker Chevrolet. Mr. Adkins attended the University of Maryland where he studied marketing and business management. Mr. Adkins studied marketing at the University of Cincinnati and law at Bryant and Stranton Business College. Mr. Adkins' substantial business and marketing experience will help us as we develop the Company's products and business.




1 Research Court, Suite 450 Rockville, MD 20850